{"subject":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","page_title":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","episode":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","section_path":["LM_obs3 2f646f2986ee80daa439daec387f9ad7"],"source_doc_id":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs3 2f646f2986ee80daa439daec387f9ad7-49","focus_area":"Pregnancy Liver Disorders ICP HELLP AFLP","tags":["usmle-step2","obstetrics","icp","hellp","aflp","liver-disorder"],"text":"# Liver Disorders in Late Pregnancy: ICP vs HELLP vs AFLP\n## ICP\n- 핵심 증상: 손바닥/발바닥 심한 소양감, 발진 없음.\n- bile acid 상승(보통 >10), 경도 transaminitis 가능.\n- 태아 위험(IUFD) 때문에 37주 분만 전략.\n- 약물: ursodeoxycholic acid.\n\n## HELLP\n- hemolysis + elevated liver enzymes + low platelets.\n- RUQ/epigastric pain, preeclampsia 맥락에서 응급.\n- 산모 안정화(MgSO4, BP control) 후 즉시 분만.\n\n## AFLP\n- jaundice/vomiting/encephalopathy + hypoglycemia.\n- ammonia 상승, coagulopathy(DIC) 동반 가능.\n- 원인 연관: fetal fatty-acid oxidation 결함(LCHAD).\n- 처치: 즉시 분만 + glucose/coagulation support.\n\n| Disorder | Signature clue | Lab hallmark | Delivery timing |\n| --- | --- | --- | --- |\n| ICP | itch palms/soles, no rash | bile acid↑ | 37주 분만 |\n| HELLP | RUQ pain + HTN context | platelets↓/hemolysis/LFT↑ | 즉시 분만 |\n| AFLP | confusion + jaundice | hypoglycemia + DIC | 즉시 분만 |"}
{"subject":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","page_title":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","episode":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","section_path":["LM_obs3 2f646f2986ee80daa439daec387f9ad7"],"source_doc_id":"LM_obs3 2f646f2986ee80daa439daec387f9ad7","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_obs3 2f646f2986ee80daa439daec387f9ad7-69","focus_area":"Pseudocyesis and Substance Related Obstetric Risk","tags":["usmle-step2","obstetrics","pseudocyesis","cocaine","placental-abruption"],"text":"# Pseudocyesis and Illicit Drug-Related Obstetric Risk\n## Pseudocyesis\n- 임신 확신 + 신체증상(오심/복부팽만/무월경)이나 urine hCG(-), ultrasound empty uterus.\n- malingering과 구분: 강한 심리요인이 신체증상으로 표현되는 상태.\n- 관리: 먼저 기질적 원인 배제 후 정신건강 개입.\n\n## Cocaine and placental abruption\n- no prenatal care + painful bleeding + rigid uterus는 abruption 강의심.\n- cocaine 유발 vasoconstriction/HTN이 태반 조기박리 위험 증가.\n- 산모-태아 동시 소생 및 신속 분만 판단 필요.\n\n## Rapid recap anchors\n- ICP: itching without rash, UDCA + 37주 분만.\n- AFLP: hypoglycemia/encephalopathy가 핵심 감별점.\n- pseudocyesis: organic workup 이후 psych support."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-1","focus_area":"Esophageal Dysphagia and Achalasia Core","tags":["usmle-step2","gastroenterology","dysphagia","achalasia","gerd"],"text":"# Esophageal Disorders Core: Dysphagia to Achalasia\n## Dysphagia first split\n- oropharyngeal(삼킴 시작 문제, 기침/비강역류) vs esophageal(흉골 뒤 걸림).\n- esophageal에서 solids only면 mechanical obstruction, solids+liquids면 motility disorder 우선.\n\n## Achalasia workup sequence\n- initial: barium swallow(bird-beak).\n- confirmatory: manometry(aperistalsis + LES relaxation failure).\n- 반드시 EGD로 pseudo-achalasia(암) 배제, 특히 고령/체중감소.\n\n## Diagnostic logic\n- mechanical suspicion: barium 후 EGD.\n- motility suspicion: barium 후 manometry."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-21","focus_area":"Pill Esophagitis GERD EoE Stress Ulcer Prophylaxis","tags":["usmle-step2","gastroenterology","pill-esophagitis","gerd","eoe","icu-prophylaxis"],"text":"# Esophageal Therapeutics: Pill Injury, GERD, EoE, ICU Prophylaxis\n## Pill-induced esophagitis\n- 위험약: tetracyclines, NSAIDs/aspirin, bisphosphonates, potassium/iron.\n- 물 없이 복용 후 눕는 습관이 전형적.\n- 치료: 원인약 중단/복용법 교정.\n\n## GERD strategy\n- 전형 증상 + alarm 없음: lifestyle + PPI trial.\n- alarm(연하곤란, 체중감소, 출혈/빈혈, 지속구토) 또는 고위험군은 EGD 우선.\n\n## Eosinophilic esophagitis\n- atopy 배경 + food impaction, PPI 불충분 반응.\n- 진단: biopsy에서 eosinophils 증가.\n- 치료: elimination diet, PPI, swallowed topical steroid.\n\n## Stress ulcer prophylaxis\n- 모든 입원 환자 대상이 아님.\n- major risk(예: 기계환기>48h, coagulopathy 등)에서 예방적 PPI/H2 blocker 고려."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"recap_summary","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-37","focus_area":"Rapid Recap Esophagus Algorithm","tags":["usmle-step2","gastroenterology","recap","dysphagia","achalasia","eoe"],"text":"# Rapid Recap: Esophagus Algorithms\n| Vignette | Interpretation | Next step |\n| --- | --- | --- |\n| solids then liquids progression | mechanical obstruction | barium -> EGD |\n| solids and liquids from start | motility disorder | barium -> manometry |\n| bird-beak + marked weight loss | pseudo-achalasia 가능 | EGD로 malignancy 배제 |\n| pill before sleep + odynophagia | pill esophagitis | offending drug stop/education |\n| young atopic male + impaction | EoE | biopsy + dietary/steroid strategy |\n| ICU ventilator >48h | stress-ulcer risk | prophylaxis 고려 |"}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-47","focus_area":"Stomach Pathology Toxic Functional Mechanical","tags":["usmle-step2","gastroenterology","gastropathy","cyclic-vomiting","gastroparesis","goo"],"text":"# Stomach Pathology Framework: Toxic vs Functional vs Mechanical\n## Toxic injury\n- alcohol + cocaine + NSAID 조합은 ischemia + mucosal defense 저하 + direct toxicity로 acute erosive gastropathy 유발.\n\n## Functional disorders\n- cyclic vomiting syndrome: stereotyped episodes + episode 사이 완전 정상.\n- migraine 연관이 흔함.\n\n## Motility/constipation pharmacology\n- opioid induced constipation는 연동운동 억제.\n- stimulant laxative 남용은 electrolyte/protein loss 패턴 동반 가능.\n\n## Mechanical obstruction\n- gastric outlet obstruction은 physical blockage이며 decompression/definitive intervention 필요."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-67","focus_area":"Gastroparesis versus Gastric Outlet Obstruction","tags":["usmle-step2","gastroenterology","gastroparesis","gastric-outlet-obstruction","succussion-splash"],"text":"# Gastroparesis vs Gastric Outlet Obstruction\n| Item | Gastroparesis | Gastric outlet obstruction |\n| --- | --- | --- |\n| Core mechanism | autonomic neuropathy로 기능 저하 | 물리적 폐쇄(궤양반흔/암 등) |\n| Typical clues | 조기포만, 미소화 음식 구토, 혈당 변동 | projectile non-bilious vomiting, succussion splash |\n| Evaluation order | EGD로 폐쇄 배제 후 gastric emptying study | 내시경/영상으로 폐쇄 확인 |\n| Initial treatment | 식이조절 + prokinetic | NPO/NG decompression/수액 |\n\n## Gastroparesis\n- 장기 당뇨의 autonomic neuropathy가 흔한 원인.\n- metoclopramide, 단기 erythromycin 사용 가능.\n\n## GOO\n- 기계적 폐쇄 의심 상태에서 prokinetic 남용은 위험.\n- definitive treatment는 내시경 확장 또는 수술."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-87","focus_area":"Jaundice Algorithm and Cholestatic Workup","tags":["usmle-step2","gastroenterology","jaundice","cholestasis","biliary-obstruction"],"text":"# Jaundice Diagnostic Algorithm\n## First step\n- bilirubin fractionation으로 unconjugated vs conjugated 구분.\n\n## Unconjugated dominant\n- hemolysis 또는 conjugation 장애(Gilbert 등) 평가.\n- Gilbert는 경도/간효소 정상/안심설명 중심.\n\n## Conjugated dominant\n- AST/ALT 우세면 hepatocellular injury.\n- ALP 우세면 cholestatic process로 영상평가 진행.\n\n| Pattern | Likely process | Next move |\n| --- | --- | --- |\n| indirect bili dominant | hemolysis or conjugation defect | CBC/retic/hemolysis panel, clinical context |\n| direct bili + AST/ALT 상승 | hepatitis/hepatocellular injury | 원인검사(viral/drug/autoimmune) |\n| direct bili + ALP 상승 | obstructive/intrahepatic cholestasis | RUQ US -> CT/MRCP/ERCP 필요시 |\n\n## Malignant obstruction clues\n- painless jaundice, pruritus, pale stool, dark urine, Courvoisier sign."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-107","focus_area":"Acute Liver Failure and Cirrhosis Fundamentals","tags":["usmle-step2","gastroenterology","acute-liver-failure","cirrhosis","nac"],"text":"# Acute Liver Failure and Cirrhosis Fundamentals\n## Acute liver failure triad\n- severe acute liver injury(AST/ALT 크게 상승).\n- synthetic failure(INR >=1.5).\n- encephalopathy 동반.\n- encephalopathy 존재가 severe hepatitis와의 핵심 구분점.\n\n## Common causes and specific therapy\n- viral(A/B/E), acetaminophen, ischemic injury, autoimmune, Wilson.\n- acetaminophen toxicity는 NAC 조기 투여가 핵심.\n\n## Cirrhosis overview\n- portal HTN + 합성기능 저하(albumin low/INR high/platelet low).\n- AST/ALT가 정상이어도 진행 간질환 배제 불가.\n- 기본: 원인치료, 예방접종, 합병증 screening(EGD/HCC surveillance)."}
{"subject":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","page_title":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","episode":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","section_path":["LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3"],"source_doc_id":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3","source_page":null,"chunk_type":"transcript_chunk","source_anchor":"LM_GIT 1 2f746f2986ee80c5bf7bfff60573e7e3-127","focus_area":"Cirrhosis Complications Ascites SBP Encephalopathy","tags":["usmle-step2","gastroenterology","variceal-bleeding","ascites","sbp","hepatic-encephalopathy"],"text":"# Decompensated Cirrhosis: Varices, Ascites, SBP, Encephalopathy\n## Variceal hemorrhage\n- 예방: nonselective beta blocker 또는 EVL.\n- 급성출혈: resuscitation + octreotide + ceftriaxone + urgent endoscopic therapy.\n- refractory 시 TIPS 고려(encephalopathy 악화 가능).\n\n## Ascites and SAAG\n- SAAG >=1.1은 portal hypertension 가능성 높음.\n- 치료: 염분제한 + spironolactone/furosemide(100:40 비율), 필요시 대량천자 + albumin.\n- NSAID는 신장관류 악화로 회피.\n\n## SBP\n- paracentesis PMN >=250면 진단.\n- ceftriaxone + albumin으로 치료(신부전 예방 목적).\n- 재발고위험군은 prophylaxis 고려.\n\n## Hepatic encephalopathy\n- 유발인자 감염/GI bleed/변비/전해질 이상.\n- lactulose(목표 2-3회 배변) 1차, rifaximin 추가 고려.\n\n## Prognostic scores\n- Child-Pugh와 MELD(특히 creatinine/INR/bilirubin/Na)로 예후·이식 우선순위 평가."}
